摘要
前列腺癌是男性生殖系常见的恶性肿瘤,在我国的发病率逐年上升。根治性前列腺切除术已成为目前局限性前列腺癌的主要治疗方法。而作为一个整体的盆腔淋巴结清扫,在疾病分期及预后中的意义尚未完全清楚,盆腔淋巴结清扫的范围及适应证也没有完全统一。本文拟就目前国际上对前列腺癌盆腔淋巴结清扫的意义及清扫范围的研究进展作一综述。
出处
《临床泌尿外科杂志》
2008年第6期475-478,共4页
Journal of Clinical Urology
参考文献18
-
1Frazier H A II,Robertson J E,Paulson D F, Does radical prostatectomy in the presence of positive pelvic lymph-node enhance survival[J]? World J Urol, 1994, 12: 308-312.
-
2Bader P, Burkard F C, Markwalder R, et al. Disease progression and survival of patients with positive after radical prostatectomy. Is there a chance for cure[J]? J Urol, 2003,169 :849-854.
-
3Han M, Partin A W, Pound C R,et al. Long-term biochemical disease free and cancer specific survival following anatomic radical retropubic prostatectomy: the 15 year Johns Hopkins experience[J]. Urol Clin North Am,2001,28:555-565.
-
4Allaf M E, Palapattu G S, Trock B J,et al. Anatomical extent of lymph node dissection: Impact on men with clinically localized prostate cancer[J]. J Urol, 2004, 172:1840- 1844.
-
5Heidenreich A, Varga Z, Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis [J]. J Urol,2002,167:1681-1866.
-
6Joslyn S A, Konety B R. Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer[J]. J Urol.2006,68:121-125.
-
7Alekseev B, Rusakov I, Vorobyev N,et al. The role of number of lymph nodes removed during radical prostatectomy and pelivic lymphadenectomy in progrprogression-free survival of prostate cancer patient[J]. Eur Urol Suppl,2007,6(2);57.
-
8Partin A W, Kattan M W, Subong E N, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update[J]. JAMA,1997,277:1445-1451.
-
9Crawford E D, Batuello J T, Snow P,et al. The use of artificial intelligence technology to predict lymph node spread in men with clinically localized prostate carcinoma[J]. Cancer,2000,88:2105-21059.
-
10Bhatta-Dhar N, Reuther A M, Zippe C,et al. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer[J]. Urology, 2004,63 : 528- 531.
同被引文献28
-
1Heidenreich A,Bastian P J,Bellmunt J,et al.Guidelines on prostate cancer.Uroweb 2013.http://www.uroweb.org/gls/pdf/09_Prostate_C ancer_LR.pdf.
-
2Makarov DV,Trock BJ,Humphreys EB,et al.Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level,clinical stage,and biopsy Gleason score (Partin tables)based on cases from 2000 to 2005.Urology,2007,69:1095-1101.
-
3Crawford ED,Batuello JT,Snow P,et al.The use of artificial intelligence technology to predict lymph node spread in men with clinically localized prostate carcinoma.Cancer,2000,88:2105-2109.
-
4Bhatta-Dhar N,Reuther AM,Zippe C,et al.No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.Urology,2004,63:528-531.
-
5Briganti A,Larcher A,Abdollah F,et al.Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection:the essential importance of percentage of positive cores.Eur Urol,2012,61:480-487.
-
6Schumacher MC,Burkhard FC,Thalmann GN,et al.Is pelvic lymph node dissection necessary in patients with a serum PSA <10 ng/ml undergoing radical prostatectomy for prostate cancer?.Eur Urol,2006,50:272-279.
-
7Kazzazi A,Djavan B.Current status of pelvic lymph node dissection in prostate cancer:the New York PLND nomogram.Can J Urol,2011,18:5585-5591.
-
8Briganti A,Blute ML,Eastham JH,et al.Pelvic lymph node dissection in prostate cancer.Eur Urol,2009,55:1251-1265.
-
9Briganti A,Karnes JR,Da Pozzo LF,et al.Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer.A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy,extended pelvic lymph node dissection and adjuvant therapy.Eur Urol, 2009, 55:261-270.
-
10Touijer K,Fuenzalida RP,Rabbani F,et al.Extending the indications and anatomical limits of pelvic lymph node dissection for prostate cancer:improved staging or increased morbidity?.BJU Int,2011,108:372-377.
引证文献2
-
1毕海,常保东,马潞林.盆腔淋巴结清扫术在根治性前列腺切除术中的临床意义[J].中华泌尿外科杂志,2013,34(12):956-958. 被引量:3
-
2薛亚洲,李虹君,赵家红,张瑞,李晓慧,庞建智,杨晓峰.前列腺癌移植瘤近红外荧光成像最佳成像时间的实验[J].肿瘤防治研究,2019,46(6):499-503. 被引量:1
二级引证文献4
-
1朱再生,叶敏,施红旗,周一波,陈良佑,刘全启,孙鹏,胡洋,张春霆.前列腺癌淋巴结转移的特点及其临床意义[J].中华泌尿外科杂志,2014,35(11):829-832. 被引量:15
-
2谢栋栋,王毅,陈磊,张志强,闵捷,丁德茂,王大明,邹慈,毕良宽,王进有,张涛,章大钊,耿浩,于德新.腹腔镜扩大盆腔淋巴结清扫在高危前列腺癌治疗中的应用[J].安徽医科大学学报,2015,50(12):1816-1818. 被引量:3
-
3阎成全,姚林,张争,李学松,蔡林,何志嵩,周利群.腹腔镜下扩大盆腔淋巴结清扫术在高危前列腺癌治疗中的应用[J].实用医院临床杂志,2017,14(6):5-9. 被引量:3
-
4杨柳,楼敏铭,冯郸,刘微微,马洁.自然杀伤细胞对宫颈癌HeLa细胞裸鼠移植瘤的治疗效果[J].肿瘤药学,2020,10(4):440-445. 被引量:2
-
1刘玲,金润铭.儿童急性混合细胞型白血病的研究现状[J].世界核心医学期刊文摘(儿科学分册),2005,1(3):1-3.
-
2瞿文荧,晏爱立,陈正中,姚卫康,季生发.家族性腺瘤性息肉病的外科治疗[J].中华当代医学,2005,3(11):9-10.
-
3段晨阳,刘梦颖(综述),王燕(审校).miRNAs与前列腺癌——靶向治疗新进展[J].中国男科学杂志,2012,26(9):63-64.
-
4白雪莲,武云,于德东,都志强.89SrCl2结合外照射治疗前列腺癌骨转移23例临床分析[J].中外医学研究,2010,8(30):31-31.
-
5张涛.乳腺分叶状肿瘤诊治分析[J].山东医学高等专科学校学报,2014,36(4):313-315.
-
6黄文斌,程亮.易与前列腺癌混淆的前列腺良性病变的病理学诊断[J].临床与实验病理学杂志,2012,28(10):1067-1073. 被引量:6
-
7程亮,黄文斌,李媛,王丽莎.易与前列腺癌混淆的前列腺良性病变的病理学诊断及鉴别诊断[J].中华病理学杂志,2014,43(1):52-58. 被引量:7
-
8钱伟庆.机器人辅助腹腔镜下根治性前列腺切除术[J].老年医学与保健,2015,21(4):202-204. 被引量:1
-
9冯艳红.前列腺癌患者的生活质量和相关因素分析及护理干预[J].中国现代药物应用,2012,6(3):114-115. 被引量:4
-
10饶健章,唐令超.胃类癌的近代认识[J].中国实用外科杂志,2007,27(7):565-567. 被引量:3